Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126455351 | 12645535 | 1 | I | 20160704 | 20160802 | 20160811 | 20160811 | EXP | GB-MHRA-EYC 00143055 | GB-MYLANLABS-2016M1032406 | MYLAN | 0.00 | Y | 0.00000 | 20160811 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126455351 | 12645535 | 1 | PS | ZOLEDRONIC ACID | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | UNK | Y | U | 202650 | ||||||||
| 126455351 | 12645535 | 2 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | UNK | U | 0 | ||||||||||
| 126455351 | 12645535 | 3 | C | CARBOCISTEINE | CARBOCYSTEINE | 1 | UNK | U | 0 | ||||||||||
| 126455351 | 12645535 | 4 | C | CICLESONIDE | CICLESONIDE | 1 | U | 0 | |||||||||||
| 126455351 | 12645535 | 5 | C | ZOPICLONE | ZOPICLONE | 1 | U | 0 | |||||||||||
| 126455351 | 12645535 | 6 | C | SALMETEROL | SALMETEROL | 1 | U | 0 | |||||||||||
| 126455351 | 12645535 | 7 | C | SOLPHYLLIN | 2 | U | 0 | ||||||||||||
| 126455351 | 12645535 | 8 | C | TIOTROPIUM | TIOTROPIUM | 1 | U | 0 | |||||||||||
| 126455351 | 12645535 | 9 | C | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | U | 0 | |||||||||||
| 126455351 | 12645535 | 10 | C | COCODAMOL | ACETAMINOPHENCODEINE PHOSPHATE | 1 | UNK | U | 0 | ||||||||||
| 126455351 | 12645535 | 11 | C | SALBUTAMOL | ALBUTEROL | 1 | UNK | U | 0 | ||||||||||
| 126455351 | 12645535 | 12 | C | ZAFIRLUKAST. | ZAFIRLUKAST | 1 | UNK | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126455351 | 12645535 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126455351 | 12645535 | Chronic obstructive pulmonary disease | |
| 126455351 | 12645535 | Dyspnoea | |
| 126455351 | 12645535 | Hypersensitivity | |
| 126455351 | 12645535 | Malaise | |
| 126455351 | 12645535 | Nausea | |
| 126455351 | 12645535 | Pain | |
| 126455351 | 12645535 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126455351 | 12645535 | 1 | 20160704 | 20160704 | 0 |